ArticleJournal of experimental & clinical cancer research : CR2019

Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.

Yujia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.